Aerovate Therapeutics (AVTE)
NASDAQ:AVTE
US Market
Holding AVTE?
Track your performance easily

Aerovate Therapeutics (AVTE) Financial Statements

120 Followers

Aerovate Therapeutics Financial Overview

Aerovate Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.14; its P/E ratio is -0.61; Aerovate Therapeutics is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.58. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -26.16M$ -24.62M$ -22.07M$ -19.59M$ -19.05M
EBITDA$ -26.14M$ -24.59M$ -22.04M$ -20.37M$ -19.66M
Net Income Common Stockholders$ -24.77M$ -23.19M$ -20.41M$ -19.59M$ -19.02M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 104.20M$ 99.33M$ 122.44M$ 135.20M$ 150.10M
Total Assets$ 111.69M$ 106.82M$ 127.42M$ 140.88M$ 155.75M
Total Debt$ 681.00K$ 774.00K$ 675.00K$ 809.00K$ 855.00K
Net Debt$ -103.52M$ -98.56M$ -121.76M$ -134.39M$ -149.24M
Total Liabilities$ 17.30M$ 15.92M$ 17.96M$ 15.15M$ 13.83M
Stockholders Equity$ 94.40M$ 90.90M$ 109.46M$ 125.72M$ 141.93M
Cash Flow-
Free Cash Flow$ -20.43M$ -23.67M$ -14.86M$ -15.64M$ -14.97M
Operating Cash Flow$ -20.43M$ -23.67M$ -14.80M$ -15.61M$ -14.94M
Investing Cash Flow$ 18.00M$ 8.83M$ 5.65M$ -13.13M$ 3.98M
Financing Cash Flow$ 24.38M$ 471.00K$ 463.00K$ 20.00K$ 45.29M
Currency in USD

Aerovate Therapeutics Earnings and Revenue History

Aerovate Therapeutics Debt to Assets

Aerovate Therapeutics Cash Flow

Aerovate Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis